BamSEC and AlphaSense Join Forces
Learn More

Xencor Inc. – Material Contracts

NASDAQ: XNCR    
Share price (3/13/26): $12.00    
Market cap (3/13/26): $880 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.7
from 10-K 8 pages Xencor, Inc. Amended and Restated 2023 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.6
from 10-K 7 pages Xencor, Inc. Amended and Restated 2023 Equity Incentive Plan Option Agreement
12/34/56
EX-10.2
from 10-Q 8 pages Xencor, Inc. Consulting Agreement Effective Date: June 6, 2025
12/34/56
EX-10.1
from 10-Q 4 pages Seventh Amendment to Lease
12/34/56
EX-10.1
from 10-Q 25 pages Xencor, Inc. Amended and Restated 2023 Equity Incentive Plan Adopted by the Board of Directors: April 18, 2025 Approved by the Stockholders: June 12, 2025
12/34/56
EX-10.1
from 10-Q 7 pages ***Certain Identified Information Has Been Excluded From the Exhibit Because It Both (I) Is Not Material and (II) Is the Type That the Company Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[...***...]”) in This Exhibit.*** April 19, 2024 John Kuch [...***...] [...***...] Re: Separation Agreement Dear John,
12/34/56
EX-10.34
from 10-K 59 pages Research and License Agreement
12/34/56
EX-10.30
from 10-K 3 pages Confidential
12/34/56
EX-10.29
from 10-K 71 pages Collaboration and License Agreement
12/34/56
EX-10.7
from 10-K 8 pages Xencor, Inc. 2023 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.6
from 10-K 7 pages Xencor, Inc. 2023 Equity Incentive Plan Option Agreement
12/34/56
EX-10.2
from 10-Q 1 page Executive Employment Letter Addendum #2
12/34/56
EX-10.1
from 10-Q 10 pages Xencor, Inc. Consulting Agreement Effective Date: April 19, 2024
12/34/56
EX-10.4
from 10-Q 3 pages Fourth Amendment to the License Agreement by and Between Xencor, Inc. and Morphosys AG [Remainder of Page Intentionally Left Blank.]
12/34/56
EX-10.3
from 10-Q 4 pages Material contract
12/34/56
EX-10.2
from 10-Q 5 pages Material contract
12/34/56
EX-10.1
from 10-Q 14 pages Third Amendment to Lease
12/34/56
EX-10.47
from 10-K 70 pages Amended and Restated Collaboration and License Agreement by and Between, on the One Hand, Xencor, Inc., And, on the Other Hand, Genentech, Inc. and F. Hoffmann-La Roche Ltd, Effective as of June 1, 2024
12/34/56
EX-10.2
from 10-Q 24 pages Executive Employment Agreement Addendum
12/34/56
EX-10.1
from 10-Q 23 pages Executive Employment Agreement Addendum
12/34/56